Obesity remains one of the most pressing public health challenges in the United States and worldwide. Despite the availability of FDA-approved weight loss drugs like GLP-1 receptor agonists (e.g., Ozempic), new research from 2025 is shedding light on a surprising potential ally in obesity management: ivermectin. Initially known as an antiparasitic drug, ivermectin has captured attention in...